Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lynn R. Webster, Eugene R. Viscusi, Colville Brown & Jeffrey M. Dayno. (2018) Human abuse potential studies of abuse-deterrent opioids: lessons from oral and intranasal studies with morphine abuse-deterrent, extended-release, injection-molded tablets. Current Medical Research and Opinion 34:5, pages 893-901.
Read now
Read now
Articles from other publishers (4)
Nicole S. Jones & Jeffrey H. Comparin. (2020) Interpol review of controlled substances 2016–2019. Forensic Science International: Synergy 2, pages 608-669.
Crossref
Crossref
Torben Elhauge, Sebastian Schwier, Stephen W. Hoag, Beatrice Setnik, Robert Bianchi, Christopher Altomare, Penny Toren & Karsten Lindhardt. (2019) Standardization of In Vitro Testing During Development of Abuse‐Deterrent Opioids: Highlights From the Second and Third Category 1 Focus Group Meetings. Pain Practice 19:6, pages 580-585.
Crossref
Crossref
Lindsay P. Schwartz, Peter G. Roma, Jack E. Henningfield, Steven R. Hursh, Edward J. Cone, August R. Buchhalter, Reginald V. Fant & Sidney H. Schnoll. (2019) Behavioral economic demand metrics for abuse deterrent and abuse potential quantification. Drug and Alcohol Dependence 198, pages 13-20.
Crossref
Crossref
Richard L. Rauck. (2019)
Mitigation of
IV
Abuse Through the Use of Abuse‐Deterrent Opioid Formulations: An Overview of Current Technologies
. Pain Practice 19:4, pages 443-454.
Crossref
Crossref